What is a stock summary page? Click here for an overview.
Business Description
Humana AB
ISIN : SE0008040653
Compare
Compare
Traded in other countries / regions
HUM.Sweden0RF7.UK47H.Germany IPO Date
2016-04-11Description
Humana AB is a provider of private care services in the Nordic region. It offers services including individual and family care, personal assistance, elderly care and housing with special services. Its operating segments includes Individual and Family; Personal Assistance; Elderly Care; Finland; Norway and others. The company generates the majority of its revenue from personal assistance services.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.11 | |||||
| Equity-to-Asset | 0.3 | |||||
| Debt-to-Equity | 1.63 | |||||
| Debt-to-EBITDA | 4.84 | |||||
| Interest Coverage | 1.63 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 1.51 | |||||
| Beneish M-Score | -2.82 | |||||
| WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 6.9 | |||||
| 3-Year EBITDA Growth Rate | 4.2 | |||||
| 3-Year EPS without NRI Growth Rate | -16.5 | |||||
| 3-Year FCF Growth Rate | 13.2 | |||||
| 3-Year Book Growth Rate | 4.6 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 30.65 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 3.73 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 61.74 | |||||
| 9-Day RSI | 56.46 | |||||
| 14-Day RSI | 54.07 | |||||
| 3-1 Month Momentum % | 26.04 | |||||
| 6-1 Month Momentum % | 26.21 | |||||
| 12-1 Month Momentum % | 72.82 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.87 | |||||
| Quick Ratio | 0.87 | |||||
| Cash Ratio | 0.21 | |||||
| Days Sales Outstanding | 39.51 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Forward Dividend Yield % | 2.25 | |||||
| 3-Year Average Share Buyback Ratio | -2.7 | |||||
| Shareholder Yield % | 2.23 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | 4.52 | |||||
| Net Margin % | 1.4 | |||||
| FCF Margin % | 8.43 | |||||
| ROE % | 4.75 | |||||
| ROA % | 1.38 | |||||
| ROIC % | 3.29 | |||||
| 3-Year ROIIC % | -0.97 | |||||
| ROC (Joel Greenblatt) % | 13.17 | |||||
| ROCE % | 6.05 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 15.66 | |||||
| Forward PE Ratio | 9.29 | |||||
| PE Ratio without NRI | 15.66 | |||||
| Shiller PE Ratio | 10.05 | |||||
| Price-to-Owner-Earnings | 2.91 | |||||
| PEG Ratio | 1.65 | |||||
| PS Ratio | 0.22 | |||||
| PB Ratio | 0.72 | |||||
| Price-to-Free-Cash-Flow | 2.58 | |||||
| Price-to-Operating-Cash-Flow | 2.58 | |||||
| EV-to-EBIT | 14.35 | |||||
| EV-to-EBITDA | 6.5 | |||||
| EV-to-Revenue | 0.67 | |||||
| EV-to-FCF | 7.97 | |||||
| Price-to-GF-Value | 1.37 | |||||
| Price-to-Projected-FCF | 0.19 | |||||
| Price-to-DCF (Earnings Based) | 1.16 | |||||
| Price-to-DCF (FCF Based) | 0.09 | |||||
| Price-to-Peter-Lynch-Fair-Value | 1.62 | |||||
| Earnings Yield (Greenblatt) % | 6.97 | |||||
| FCF Yield % | 39.13 | |||||
| Forward Rate of Return (Yacktman) % | 41.53 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Humana AB Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil kr) | 10,300 | ||
| EPS (TTM) (kr) | 2.82 | ||
| Beta | -0.31 | ||
| 3-Year Sharpe Ratio | -0.01 | ||
| 3-Year Sortino Ratio | -0.02 | ||
| Volatility % | 39.09 | ||
| 14-Day RSI | 54.07 | ||
| 14-Day ATR (kr) | 0.956304 | ||
| 20-Day SMA (kr) | 43.23375 | ||
| 12-1 Month Momentum % | 72.82 | ||
| 52-Week Range (kr) | 25.45165 - 48.7 | ||
| Shares Outstanding (Mil) | 50.25 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Humana AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Humana AB Stock Events
| Event | Date | Price (kr) | ||
|---|---|---|---|---|
| No Event Data | ||||
Humana AB Frequently Asked Questions
What is Humana AB(LTS:0RF7)'s stock price today?
The current price of LTS:0RF7 is kr44.40. The 52 week high of LTS:0RF7 is kr48.70 and 52 week low is kr25.45.
When is next earnings date of Humana AB(LTS:0RF7)?
The next earnings date of Humana AB(LTS:0RF7) is 2025-04-24.
Does Humana AB(LTS:0RF7) pay dividends? If so, how much?
Humana AB(LTS:0RF7) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers